NetworkNewsAudio Archive - NetworkNewsWire

WednesdayOct 02, 2019 3:30 pm

NetworkNewsAudio – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Interview

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) is a Toronto Stock Exchange and NASDAQ Global Select-listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult-recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands including the Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick, and the company is regulated…

WednesdayOct 02, 2019 11:30 am

NetworkNewsAudio – CloudCommerce (CLWD) Interview

CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven, business-intelligence and digital-marketing solutions. The company’s flagship solution, SWARM, analyzes a robust mix of audience data to help businesses find who to talk to and what to say to when they motivate those businesses to take meaningful action. CloudCommerce does this by applying advanced data science, behavioral science, artificial intelligence and market-research techniques to discover, develop and create custom audiences for any business activity. With applications such as marketing, brand perception, customer-relationship management, human-resources management and operational logistics, SWARM delivers powerful, audience-driven business intelligence to convert opportunities into business success. For…

ThursdaySep 26, 2019 8:00 am

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Building Encouraging New Breast Cancer Treatment Options

Related Editorial Advances in biotechnology look to deliver promising new treatment options against breast cancer. Independent researchers have found that Genprex Inc.’s (NASDAQ: GNPX) (GNPX Profile) TUSC2 prevented tumor growth against triple-negative breast cancer. Eli Lilly and Company (NYSE: LLY) is focusing on those patients with the greatest need and, in the process, has developed a new breast-cancer treatment option. Roche Holding (OTCQX: RHHBY) is expanding the use of its biotech to both identify and treat patients with challenging breast cancers. AbbVie Inc. (NYSE: ABBV) has been rapidly increasing its research, targeting more than 15 different types of cancer. AstraZeneca…

TuesdaySep 24, 2019 11:00 am

NetworkNewsAudio – Xalles Holdings Inc. (XALL) Interview

Xalles Holdings (OTC: XALL) is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (“TAM”), and lucrative exit opportunities. The company places emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams. For more information, visit the company’s website at www.Xalles.com. NOTE TO INVESTORS: The latest news and updates relating to XALL are available in…

MondaySep 16, 2019 6:18 pm

NetworkNewsAudio – SRAX Inc. (NASDAQ: SRAX) Interview

SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX's technology unlocks data to reveal brands' core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through the BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX's tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising…

MondaySep 09, 2019 4:00 pm

NetworkNewsAudio – Quest Patent Research Corp. (QPRC) Interview

Quest Patent Research (OTCQB: QPRC) operates as an intellectual-property, asset-management company delivering financial, strategic and legal resources for IP monetization. It partners with inventors, businesses, corporations and law firms to fully realize the value of IP assets through its suite of value-added services. Quest currently owns, controls or manages more than 115 patents across 11 intellectual property portfolios. Quest trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. For more information, visit the company’s website at www.QPRC.com. NOTE TO…

FridaySep 06, 2019 8:00 am

NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Making Significant Advances in Drug Delivery

Related Editorial Drugs play an essential role in treating anything from a mild headache to life-threatening disease — and everything in between. While effectiveness of drugs is what most often captures the spotlight, that effectiveness is closely associated with the drug-delivery technology used, and innovation in this space may have a huge impact on how successful a drug can be. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed one of the most innovative drug-delivery systems seen in years, a system that can be used to deliver a wide range of drugs in a more palatable and effective…

FridaySep 06, 2019 8:00 am

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Developing Revolutionary Gene Therapies to Fight Cancer

Related Editorial Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is focused on using gene therapy to tackle lung cancer, developing new drugs that can be used alongside existing treatments. Pfizer Inc. (NYSE: PFE) has created a state-of-the-art research center focused on gene therapy treatments, which it uses for illnesses including cancer. Gilead Sciences Inc. (NASDAQ: GILD) is using biotechnology to tackle a range of challenging diseases, including HIV and hepatitis. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is developing 20 different genetic…

WednesdaySep 04, 2019 8:23 am

NetworkNewsAudio – ORHub Inc. (ORHB) Interview

ORHub Inc. (OTC: ORHB) is a growth-stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power of data captured in the operating room by surfacing key business indicators into a curated set of dynamic dashboards. For more information, visit the company’s website at www.orhub.com. NOTE TO INVESTORS: The latest news and updates relating to ORHB are available in the company’s newsroom at http://nnw.fm/ORHB About NetworkNewsAudio NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and…

WednesdayAug 28, 2019 4:15 pm

NetworkNewsAudio – Neutra Corp. (NTRR) Interview

Neutra (OTCQB: NTRR) is an early-stage research and development company committed to bringing modern, healthy-living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture — one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical submarkets is the new, thriving, hemp-based CBD market, in which the company intends to participate. For more information, visit the company’s website at www.Neutrainc.com. NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in…